| 0 | ℹ |
Phase 1, first-in-human, randomized, placebo-controlled, dose-escalating study to evaluate OVX033, a nucleocapsid-based SARS-CoV-2 candidate vaccine.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-08-12 | #covid-19 #vaccination #immunogenicity #clinical trial #safety | |
| 0 | ℹ |
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection.
(nature.com)
|
Nature Communications 2026-08-12 | #covid-19 #variants #spike-protein #mutagenesis #transmissibility | |
| 0 | ℹ |
Evaluation of short-term multi-target respiratory forecasts over winter 2024-25 in England using sub-ensemble contribution analyses.
(journals.plos.org)
|
PLOS Computational Biology 2026-08-12 | #covid-19 #influenza #forecasting #epidemiology #ensemble |